ESPA fb in yt



A highly concentrated and re-esterified biomarine formulation for Diabetic Retinopathy (4 clinical studies).

Eyeaspis Re-D is a specially formulated dietary supplement that addresses a fundamental need for patients at risk of developing Diabetic Retinopathy. Eyeaspis Re-D as part of the daily regimen can slow the advancement to Diabetic Retinopathy and to assist in delaying vision loss. 

Eyeaspis Re-D is produced in a purified re-esterefied triglyceride form (rTG) provided up to 600mg of specific Omega-3 as EPA and DHA in a 1:5 concentration.  

It has been shown in clinical studies, published in great journals, as JAMA ophthalmology-Predimed Trial & Retina, that specially formulated Omega-3 fatty acids can help reduce the risk and slow the advancement to diabetic retinopathy. 

Eyeaspis Re-D is an essential nutrient that has shown an almost 50% decrease in risk of sight threatening Diabetic Retinopathy. It supports retinal cellular metabolism, structure and function and helps to suppress retinal inflammation.   

Eyeaspis Re-D is a daily commitment and like changes in diet and increasing exercise it is important for you to manage your diabetes on a daily basis. It is recommended in all diabetes patients as about 38% of newly diagnosed people with diabetes will develop Diabetic Retinopathy within 5 years of diagnosis. 

Eyeaspis Re-D is manufactured in Norway in certified facilities. Every batch is tested for over 400 contaminants by an outside third-party lab to ensure quality and purity standards. 


Commercial rights & brand holder: Aniva International S.A. 


The product should not be used as a substitute of a well-balanced diet. This product is not intended to prevent, treat or cure any human disease.